Barrie Levitt
10Patents
3h-index
15Co-inventors
57Inventor score
Filing activity: Sep 5, 1984 → Apr 13, 2010
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6162466A | Sustained release formulation of carbamazepine | Human Necessities | 21 | Expired |
| US4628056A | Novel oxopyrimidine derivatives, pharmaceutical compositions containing them and their use as anticonvulsant, antianxiety and muscle relaxant agents | Human Necessities | 17 | Expired |
| US6756379B2 | Non-sedating barbiturate compounds as neuroprotective agents | Human Necessities | 8 | Expired |
| US7683071B2 | Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid | Human Necessities | 3 | Active |
| US7723346B2 | Non-sedating barbiturate compounds as neuroprotective agents | Human Necessities | 3 | Expired |
| US6752997B2 | Process for preparing non-hygroscopic sodium valproate composition | Human Necessities | 2 | Expired |
| US4975458A | 2-alkyl-3-benzoylbenzofurans useful for treating cardiac arrhythmia | Chemistry; Metallurgy | 1 | Expired |
| US8076346B2 | Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid | Human Necessities | 1 | Active |
| US4831054A | 2-Alkyl-3-benzoylbenzofurans useful for treating cardiac arrhythmia | Human Necessities | 1 | Expired |
| US8158639B2 | Non-sedating barbiturate compounds as neuroprotective agents | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.